There was a trend that more helical domain PIK3CA mutations were observed in patients with lymph node metastasis staged II∼III, but the difference did not reach statistical significance ( Table S1 in File S1 ).
← all excerpts
PIK3CA mutations frequently coexist with EGFR/KRAS mutations in non-small cell lung cancer and suggest poor prognosis in EGFR/KRAS wildtype subgroup.
1
—
—